Sauer Arnaud, Hansmann Yves, Jaulhac Benoît, Bourcier Tristan, Speeg-Schatz Claude
Departments of Ophthalmology, Pole Specialty Medecine Ophthalmology Hygiene, Hopitaux Universitaires de Strasbourg, Strasbourg, France.
Clin Infect Dis. 2009 Mar 15;48(6):756-9. doi: 10.1086/597041.
Lyme borreliosis is the most common human tick-borne disease in the Northern Hemisphere. The prevalence of Lyme borreliosis is estimated to be 20-100 cases per 100,000 persons in the United States and 100-155 cases per 100,000 persons in Europe [ 1 , 2 ]. It is caused by the spirochete Borrelia burgdorferi sensu lato [ 2 , 3 ]. The course of clinical manifestations is thought to occur in 3 stages: early, disseminated, and chronic [ 2 , 4 ]. Lyme borreliosis can cause a variety of ocular manifestations, and the frequency of these manifestations among cases of Lyme disease involving systemic manifestations is approximately 1% [ 5 ].